Lysergol

• CAT Number: R018364
• CAS Number: 602-85-7
• Molecular Formula: C16H18N2O
• Molecular Weight: 254.333
• Purity: ≥95%
• Synonyms: Indolo[4,3-fg]quinoline, ergoline-8-methanol deriv.; NSC 196867; 9,10-Didehydro-6-methyl-ergoline-8β-methanol; 9,10-Didehydro-6-methyl-ergoline-8-methanol
• Storage: -20°C
• IUPAC Name: [(6aR,9R)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-yl]methanol
• InChI: InChI=1S/C16H18N2O/c1-18-8-10(9-19)5-13-12-3-2-4-14-16(12)11(7-17-14)6-15(13)18/h2-5,7,10,15,17,19H,6,8-9H2,1H3/t10-,15-/m1/s1
• InChIKey: BIXJFIJYBLJTMK-MEBBXXQBSA-N
• SMILES: CN1C[C@@H](C=C2[C@H]1CC3=CNC4=CC=CC2=C34)CO

Lysergol(CAT:R018364) is an alkaloid derived from the ergot fungus, known for its structural similarity to lysergic acid, the precursor to a variety of ergot alkaloids. This compound exhibits biological activity and has been studied for its effects on the central nervous system, particularly its interaction with serotonin receptors. Lysergol is of interest in pharmacological research due to its potential vasoconstrictive and psychoactive properties, although it is less potent than other ergot derivatives like LSD or ergotamine. In addition to its role in neuropharmacology, Lysergol is also explored for its use in synthesizing other ergot-based compounds, which have applications in treating migraines, inducing labor, and controlling bleeding postpartum. Its study contributes to the broader understanding of ergot alkaloids and their impact on human health.